N/A
Manufactured by ANI Pharmaceuticals, Inc.
35,549 FDA adverse event reports analyzed
Last updated: 2026-04-14
INDAPAMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ANI Pharmaceuticals, Inc.. The most commonly reported adverse reactions for INDAPAMIDE include HYPONATRAEMIA, ACUTE KIDNEY INJURY, DYSPNOEA, DIZZINESS, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for INDAPAMIDE.
Out of 17,198 classified reports for INDAPAMIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 35,549 FDA FAERS reports that mention INDAPAMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include HYPONATRAEMIA, ACUTE KIDNEY INJURY, DYSPNOEA, DIZZINESS, NAUSEA, DIARRHOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list ANI Pharmaceuticals, Inc. in connection with INDAPAMIDE. Always verify the specific product and NDC with your pharmacist.